explore -WSS

explore

author：Wikipedia 2025-08-11 05:32:42 - browse：947

medical science concept with a collage of human organs in anatomically correct position like brain, heart, liver, etc, isolated on black background with copy space. -- health coverage from STAT — Adobe

In today’s mostly plague- and famine-free world, if you can avoid more modern scourges like gun and car violence, you can expect your death to arrive not with a bang but a whimper; when one of your organs sput-sput-sputters out. And it is usually just oneorgan or organ system. For some, it’s a calcium-clogged heart. For others, kidneys that no longer filter. They might all work a little less well as we get older, but they don’t tend to fail all at once.

The work of geriatricians is basically to figure out which organ system in any given patient has furthest deteriorated and come up with a plan — drugs, surgeries, lifestyle changes — to put a few more good years on it. That job would be a lot easier if each of our organs came with an early warning indicator light — something that could flip on when a person is still healthy and relatively young.

With the right technology, it turns out they do, say scientists at Stanford University School of Medicine. In a study published Wednesday in Nature, they report a method for analyzing the varying rates at which organ systems age within the same person using the distinct proteins that those organs produce and shed into the blood.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Dobbs anniversary: the lost opportunity of abortion as health care
Next article： Living with Hashimoto's and celiac disease, and med school, too

WSS

HIV drugs protect against transmission, even in unprotected sex

For one rare type of lung cancer, Pfizer pill reduces progression by 81%

Woman returns to dialysis after doctors remove transplanted pig kidney

Ukraine taking heavy casualties 10 weeks into its counteroffensive

Lung cancer is America's deadliest cancer. Yet so few get screened

ProMED sees offers of support, but its future remains unclear

leisure time

explore

explore

Trump demands the U.S. pay no more for drugs than other countries … again

FDA's Pazdur wants cancer trials to range beyond China alone

Moonlake's readout produced a cash windfall. Risks remain

At ASCO, AstraZeneca reports strong data for breast cancer drug

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Kaiser's Risant Health gobbled up Geisinger. Who is next?

How to save PrEP access — and even expand it

At ASCO, pharma leaders speak of advances in 'smart bomb' drugs

Apple is now the first public company to be valued at $3 trillion

With trial win, GSK could get blood cancer drug back on market

explore

The pain doctors face in trying to build their families

FDA approves first treatment for ultra

ASCO: AstraZeneca says CAR

ActiGraph execs on goal of drug approvals with digital endpoints

Clinical trials must include more disabled people

ASCO: AstraZeneca's Tagrisso greatly slowed some lung cancers

entertainment

explore

entertainment

entertainment